N-butyl-7-chloro-N-(4-methoxyphenyl)quinolin-4-amine

ID: ALA4872221

PubChem CID: 164618667

Max Phase: Preclinical

Molecular Formula: C20H21ClN2O

Molecular Weight: 340.85

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCN(c1ccc(OC)cc1)c1ccnc2cc(Cl)ccc12

Standard InChI:  InChI=1S/C20H21ClN2O/c1-3-4-13-23(16-6-8-17(24-2)9-7-16)20-11-12-22-19-14-15(21)5-10-18(19)20/h5-12,14H,3-4,13H2,1-2H3

Standard InChI Key:  QIWLKOQCTNCYGP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    4.1583  -14.3327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1565  -12.6797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8719  -13.0888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8727  -13.9157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4435  -13.9199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4457  -13.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7330  -12.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0175  -13.0927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0192  -13.9215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7325  -14.3307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1530  -11.8546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8658  -11.4390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5815  -11.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2938  -11.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2906  -10.6092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5694  -10.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8600  -10.6171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0028  -10.1926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7196  -10.6011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4367  -11.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7239  -11.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0077  -11.4513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2969  -11.8668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3056  -14.3357    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  4  2  0
  3  2  2  0
  2  6  1  0
  3  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
  2 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  9 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872221

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 340.85Molecular Weight (Monoisotopic): 340.1342AlogP: 5.84#Rotatable Bonds: 6
Polar Surface Area: 25.36Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.36CX LogP: 5.56CX LogD: 5.53
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.56Np Likeness Score: -0.98

References

1. Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J..  (2021)  Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.,  46  [PMID:34455231] [10.1016/j.bmc.2021.116376]

Source